Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Prior to Janus kinase inhibitors, available therapies for myelofibrosis were generally supportive and did not improve survival. This analysis compares efficacy outcomes of patients with myelofibrosis in the control arms (placebo [n=154] and best available therapy [n=73]) from the two phase 3 COntrol...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Mesa, Ruben A., Kiladjian, Jean-Jacques, Verstovsek, Srdan, Al-Ali, Haifa Kathrin, Gotlib, Jason, Gisslinger, Heinz, Levy, Richard, Siulnik, Andres, Gupta, Vikas, Khan, Mahmudul, DiPersio, John F., McQuitty, Mari, Catalano, John V., Hunter, Deborah S., Knoops, Laurent, Deininger, Michael, Cervantes, Francisco, Miller, Carole, Vannucchi, Alessandro M., Silver, Richard T., Barbui, Tiziano, Talpaz, Moshe, Barosi, Giovanni, Winton, Elliott F., Mendeson, Estella, Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth, Lyons, Roger M., Paquette, Ronald, Raza, Azra, Sun, William, Sandor, Victor, Kantarjian, Hagop M., Harrison, Claire
Format: Artigo
Sprog:Inglês
Udgivet: Ferrata Storti Foundation 2014
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912959/
https://ncbi.nlm.nih.gov/pubmed/23911705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.087650
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker